Claud Worth
Claud Worth (1869–1936) was a prominent British ophthalmologist known for his contributions to the field of strabismus and orthoptics. He is best remembered for developing the Worth Four Dot Test, a diagnostic tool used to assess binocular vision and suppression.
Early Life and Education[edit | edit source]
Claud Worth was born in 1869. He pursued his medical education at St Bartholomew's Hospital in London, where he developed an interest in ophthalmology. After completing his studies, he trained under several notable ophthalmologists, which laid the foundation for his future contributions to the field.
Career[edit | edit source]
Worth's career was primarily focused on the study and treatment of strabismus, a condition where the eyes do not properly align with each other. He worked at the Royal London Hospital and later at the Moorfields Eye Hospital, where he made significant advancements in the understanding and treatment of eye disorders.
Worth Four Dot Test[edit | edit source]
One of Worth's most notable contributions is the development of the Worth Four Dot Test. This test is used to evaluate a patient's binocular vision and detect any suppression of vision in one eye. It remains a standard diagnostic tool in ophthalmology.
Publications[edit | edit source]
Worth authored several influential texts on ophthalmology, including "Squint: Its Causes, Pathology, and Treatment," which became a seminal work in the field. His writings provided valuable insights into the diagnosis and management of strabismus and other ocular conditions.
Legacy[edit | edit source]
Claud Worth's work has had a lasting impact on the field of ophthalmology. His contributions to the understanding and treatment of strabismus have improved the quality of life for countless patients. The Worth Four Dot Test continues to be widely used by eye care professionals around the world.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD